MOTS-c: Mitochondria-Derived Peptide Research and Metabolic Signalling

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a peptide encoded entirely within the mitochondrial genome, specifically within the 12S rRNA gene (MT-RNR1). Its discovery challenged the long-held assumption that the 37-gene mitochondrial genome encodes only respiratory chain proteins, tRNAs, and rRNAs. Identified by Lee et al. in 2015, MOTS-c represents a new class of bioactive molecules: mitochondria-derived peptides (MDPs).

Chemical and Molecular Data

Discovery and Genomic Context

MOTS-c is encoded within an alternative open reading frame of the 12S ribosomal RNA gene (MT-RNR1). MT-RNR1 is a structural RNA gene, not traditionally considered protein-coding. The discovery that it harbours an ORF encoding a bioactive peptide opened a new field of mitochondrial peptide biology. The 16-amino-acid sequence is translated within the mitochondrial matrix using the mitochondrial genetic code, then secreted into the cytoplasm and bloodstream where it functions as a circulating signalling molecule.

AMPK Pathway Activation

MOTS-c activates AMP-activated protein kinase (AMPK), the cell's primary energy sensor. AMPK activation promotes glucose uptake via GLUT4 translocation, fatty acid oxidation, mitochondrial biogenesis, and suppression of energy-consuming anabolic processes. AMPK is activated when the AMP/ATP ratio rises, indicating energy deficit.

Folate Cycle and AICAR Mechanism

Research has proposed that MOTS-c inhibits enzymes in folate-dependent one-carbon metabolism, leading to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a naturally occurring purine synthesis intermediate and direct pharmacological AMPK activator. This represents a mitochondria-to-nucleus signalling route, with mitochondria communicating their functional state to regulate nuclear gene expression via AICAR-AMPK signalling.

Nuclear Translocation Under Stress

Under conditions of metabolic stress including glucose deprivation, oxidative stress, and UV radiation, MOTS-c can translocate to the nucleus where it modulates stress-responsive gene expression. This non-AMPK pathway is an active area of investigation.

Age-Related Decline and Exercise Research

Circulating MOTS-c concentrations decline with advancing age in animal models and human studies, paralleling the well-documented decline in NAD+ levels. Exercise has been associated with increased MOTS-c secretion, positioning it as a potential mediator of exercise-induced metabolic benefits.

Research Applications

MOTS-c is used in AMPK pathway and energy sensing studies, mitochondrial communication research, metabolic regulation models, and cellular ageing biology.

MOTS-c research intersects with NAD+ (mitochondrial energy metabolism and ageing), SLU-PP-332 (ERR receptor activation downstream of AMPK/PGC-1alpha), 5-Amino-1MQ (NNMT inhibition and NAD+ precursor availability), and TB-500 (complementary cellular signalling research).

MOTS-c vs Other Mitochondria-Derived Peptides

Age-Related MOTS-c Research

Research has documented age-related changes in circulating MOTS-c that parallel the well-established decline in NAD+ levels:

• Plasma MOTS-c concentrations in elderly human subjects have been reported significantly lower than in young adults in several cross-sectional studies
• In mouse models, MOTS-c levels in skeletal muscle decline substantially with age, correlating with reductions in AMPK activity and glucose uptake capacity
• Exercise training in animal models has been associated with increased MOTS-c secretion from skeletal muscle, proposing it as a potential exercise-induced mitokine
• The MOTS-c decline with age appears to mirror the decline in mitochondrial biogenesis capacity and AMPK sensitivity observed in ageing muscle

Frequently Asked Questions

How does MOTS-c activate AMPK through the folate cycle?
The proposed mechanism involves MOTS-c inhibiting enzymes in the folate-dependent one-carbon metabolism pathway, specifically methylenetetrahydrofolate dehydrogenase (MTHFD). This inhibition leads to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) — a purine synthesis intermediate that directly activates AMPK by mimicking AMP. This represents an indirect AMPK activation mechanism distinct from energy depletion (which raises AMP:ATP ratio) or direct AMPK activators.

What is the significance of MOTS-c nuclear translocation?
Under metabolic stress conditions — including glucose deprivation, oxidative stress, and UV radiation — MOTS-c translocates from the cytoplasm to the nucleus. Once there, it has been shown to bind to regulatory regions of nuclear genes and modify stress-responsive gene expression. This non-AMPK function represents a direct mitochondria-to-nucleus communication pathway, where the mitochondria can influence nuclear transcription in response to stress signals.

How does MOTS-c research connect to NAD+ biology?
Both MOTS-c and NAD+ are studied in the context of mitochondrial energy metabolism and cellular ageing. MOTS-c activates AMPK, which in turn phosphorylates and activates PGC-1alpha — the master regulator of mitochondrial biogenesis. PGC-1alpha is also co-activated by SIRT1 in an NAD+-dependent manner. This creates a shared upstream convergence: both MOTS-c (via AMPK/PGC-1alpha) and NAD+ (via SIRT1/PGC-1alpha) regulate mitochondrial biogenesis through the same downstream co-activator.

For laboratory and analytical research purposes only. Not for human or veterinary use. No dosage or administration guidance is provided or implied.

Related research compounds: NAD+ | SLU-PP-332 | 5-Amino-1MQ | TB-500

View MOTS-c product page